I think the lack of interest in PYC in the past has partly to do with the fact that for the average layman investor it is difficult to understand the role of peptides in so called "drug discovery".
Most Biotechs are going directly after a particular disease or condition which investors can relate to even if they dont get the science behind it.
I think the fact that we are starting to hear about more easily undertood "Disease Targets" like say for eg. Astroneca chasing a drug to deal with a common infection encountered in hospitals is more "layman-speak" and a more attractive proposition to invest in, even if it is somewhat indirectly.
Roche hasn't helped by being tight lipped about what targets they are after and how much they are prepared to pay to get at 'em.
Maybe that will change if and when the next stage of the Roche deal is announced. Listening to the CEO's words on progress w.r.t. the Roche investigation certainly gives me positive thoughts about the outcome.
Looking forward to the next 3 to 6 months as a shareholder.
- Forums
- ASX - By Stock
- PYC
- taking up rights
taking up rights, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
14.0¢ |
Change
0.010(7.69%) |
Mkt cap ! $653.2M |
Open | High | Low | Value | Volume |
14.0¢ | 14.5¢ | 13.0¢ | $1.446M | 10.38M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 252759 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 113762 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 252759 | 0.135 |
8 | 734963 | 0.130 |
7 | 553701 | 0.125 |
7 | 374999 | 0.120 |
3 | 205000 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 113762 | 2 |
0.145 | 1545572 | 9 |
0.150 | 915500 | 11 |
0.160 | 29077 | 2 |
0.170 | 103000 | 3 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online